Press Releases
20 September 2019
BOSTON, Sept. 20, 2019 /PRNewswire/ -- Today, 3,000 Blue Cross Blue Shield of Massachusetts associates are volunteering at
Read more...20 September 2019
VANCOUVER, British Columbia, Sept. 20, 2019 /PRNewswire/ -- Natreve, the world's first certified plastic-neutral wellness and supplement company, is proud to announce its new partnershi
Read more...20 September 2019
PERTH, Australia and BILLERICA, Mass., Sept. 20, 2019 /PRNewswire/ -- Murdoch University and Bruker (Nasdaq: BRKR) today announced a strategic collaboration that will help transform the prevention and diagnosis of disease and personalised health around the world. The Murdoch-Bruker collaboration w
Read more...20 September 2019
HONG KONG, Sept. 20, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company will hold its 2019 annual general meeting of shareho
Read more...20 September 2019
TARRYTOWN, N.Y. and CAMBRIDGE, Mass., Sept. 20, 2019 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that The Lancet has
Read more...20 September 2019
INDIANAPOLIS, Sept. 20, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion recommending an update to the Trulicity® (dulaglutide) label and indication statement. The committee agreed the label should include results from the REWIND
Read more...20 September 2019
STAINES-UPON-THAMES, United Kingdom, Sept. 20, 2019 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE: MNK), a global biopharmaceutical company, will present at the Ca
Read more...20 September 2019
TARRYTOWN, N.Y. and PARIS, Sept. 20, 2019 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Dupixent® (dupilumab) in a third indicati
Read more...20 September 2019
CHICAGO, Sept. 20, 2019 /PRNewswire/ -- Rush University Medical Center provides the highest quality care of 93 major academic medical centers ranked in the 2019 Quality and Accountability Study by Vizient, Inc., the health care performance improvement organization announced September 19 at its annual conference.
Read more...20 September 2019
ALISO VIEJO, Calif., Sept. 20, 2019 /PRNewswire/ -- CathWorks today announced The CathWorks FFRangio™ System will be featured in a Satellite Program held during the 2019 TCT (Transcatheter Cardiovascular Therapeutics) annual meeting in San Francisco. The event titled "FFRangio and the Rise of Image-Based FFR", will be presented on
Read more...